Jonathan King

1 article listing Jonathan King in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial Nature Communications